Published in Vaccine Weekly, August 17th, 2005
"High rates of pertussis disease in adolescents suggest that additional boosting against pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine (dTpa-IPV; Boostrix Polio, n=440) was compared to separately administered dTpa (Boostrix) and inactivated polio virus (IPV; Imovax Polio n=219), and to DTPa-IPV (Infanrix IPV, n=I H) vaccine in a partially blind, randomized controlled trial in 10- to 14-year-olds," scientists...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly